New Delhi, May 29 (IANS) The Indian Council of Medical Research (ICMR) along with the Pune-based National Institute of Virology (NIV) and other research institutes are set to launch phase-3 clinical trials of the recombinant dengue vaccine, said Apurva Chandra, Union Health Secretary on Wednesday. He said this while addressing the BRICS (Brazil, Russia, India, China, and South Africa) Health Ministers’ Meeting on the sidelines of the 77th World Health Assembly (WHA) of the World Health Organization (WHO) in Geneva. The Health Secretary said that the BRICS Vaccine Research and Development Centre was virtually launched during India’s presidency in March 2022. “India has demonstrated active eng
Hence then, the article about icmr niv to start phase 3 clinical trials of recombinant dengue vax centre was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre )